A Letter from Vizgen CEO to Customers and Researchers

Explore new dimensions
through spatial context

The MERSCOPE TM Platform, the first high multiplexing, high resolution in situ platform to combine single-cell and spatial genomics

Learn More
Home

The next generation of genomics is here...

Vizgen is dedicated to pioneering the next generation of genomics, providing tools that demonstrate the possibilities of in situ single cell spatial genomics, setting the standard for the spatial genomics field. These tools are enabling researchers to gain new insight into the biological systems that govern human health and disease with spatial context.

Vizgen’s MERSCOPETM Platform is powered by the proprietary MERFISH (Multiplexed Error-Robust Fluorescence in situ Hybridization) technology, a quantitative and genome-scale multiplexed imaging technique for identifying nucleic acids in their native tissue environment with resolution scaling from subcellular to tissue scale.

Learn more

Featured

https://vizgen.com/wp-content/uploads/2023/05/grant-program.jpg

MERSCOPE Grant Program

View Application Details
https://vizgen.com/wp-content/uploads/2023/04/Spatial-Breast-Cancer.png

MERSCOPE PanCancer Pathways Human Panel

View Product Details
https://vizgen.com/wp-content/uploads/2023/04/mouse-brain_coronal_small-1-e1680642854217.png

MERSCOPE PanNeuro Cell Type Panel

View Product Details

What's New


Read All
Press Release
6.7.2023
Vizgen Issues Open Letter to Customers and Researchers on 10x Genomics June 1, 2023 Lawsuit Announcement in Europe
Read More
Vizgen Views
5.31.2023
Predesigned Gene Panels for Cancer and Neuronal Cell Analysis
Read More
PharmaVoice
5.24.2023
The cell ‘atlasing’ approach pushing the limits of drug discovery
Read More
Tech Bubble
5.18.2023
VIZGEN – REVOLUTIONIZING SPATIAL GENOMICS
Read More
Read All

Interested in learning more about how Vizgen can accelerate your research?

Contact Us
Upcoming Events
Top